WebMar 24, 2024 · Morphic Holding. stock was originally listed at a price of $18.00 in Jun 27, 2024. If you had invested in Morphic Holding stock at $18.00, your return over the last … WebMorphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, and …

Morphic Holding, Inc. Common Stock (MORF) - Nasdaq

WebApr 5, 2024 · The Morphic Holding Holdings stock analysis is based on the TipRanks Smart Score which is derived from 6 unique data sets including Analyst recommendations, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, ... WebFind out more about the current Morphic Holding Inc valuation measures and financial statistics. Join over 1M+ investors using GuruFocus to invest and grow their investment … immortality pros and cons

April 8, 2024 – Page 2 – Stocks Register

WebMar 1, 2024 · Morphic Holding, Inc. (MORF) came out with a quarterly loss of $0.57 per share versus the Zacks Consensus Estimate of a loss of $0.37. This compares to loss of $0.66 per share a year ago. WebMorphic is developing small molecule inhibitors of the integrin α v β 8 through a combination immuno-oncology approach for the treatment of solid tumors as well as potential additional indications. α v β 8 is known to … WebPrice To Free Cash Flow is a widely used stock evaluation measure. Find the latest Price To Free Cash Flow for Morphic (MORF) ... Morphic Holding, Inc. (MORF) Reports Q3 Loss, Lags Revenue Estimates immortality pronounce